---
title: "Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296144113.md"
description: "Vertex Pharmaceuticals (VRTX) shares rose 1.94% to $515.55, outperforming competitors like AbbVie and Krystal Biotech on a day when the broader market declined. The gain ended a three-day losing streak, though the stock remains 5.61% below its 52-week high. Trading volume was below the 50-day average."
datetime: "2026-08-17T20:37:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296144113.md)
  - [en](https://longbridge.com/en/news/296144113.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296144113.md)
generator: "portal-rs"
---

# Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. (VRTX) advanced 1.94% to $515.55 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.

The stock's rise snapped a three-day losing streak.

Vertex Pharmaceuticals Inc. closed 5.61% short of its 52-week high of $546.17, which the company reached on August 10th.

The stock outperformed some of its competitors Monday, as AbbVie Inc. (ABBV) rose 0.35% to $250.33, Krystal Biotech Inc. (KRYS) rose 1.04% to $335.73, and Arcturus Therapeutics Holdings Inc. (ARCT) fell 1.09% to $8.14.

Trading volume (1.1 M) remained 499,893 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-17-26 1637ET

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Are Wall Street Analysts Bullish on Vertex Stock?](https://longbridge.com/en/news/296449653.md)
- [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md)
- [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md)
- [Clal Insurance Enterprises Holdings Ltd Buys Shares of 2,019 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296756674.md)
- [Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296771760.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**